ZVRA
Zevra Therapeutics Inc.
11.70$
+0.5%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | 22.9% | 9.8% | 7.2% | 2.2% | 10.7% | 31.4% | 15.5% | |
| – | – | – | – | – | 77.1% | 90.2% | 92.8% | 97.8% | 89.3% | 68.6% | 84.5% | |
| – | – | – | – | – | 151.2% | 66.5% | 35.5% | 194.9% | 145.0% | 178.3% | 12.0% | |
| – | – | – | – | – | 84.2% | 59.6% | 30.4% | 151.0% | 90.1% | 232.4% | 72.9% | |
| – | – | – | – | – | 235.5% | 132.4% | 65.8% | 516.7% | 269.9% | 437.1% | 88.5% | |
| – | – | – | – | – | -158.4% | -42.2% | 27.0% | -418.9% | -180.6% | -368.5% | -4.0% | |
| – | – | – | – | – | 50.7% | 53.4% | 1.3% | 3.3% | 5.5% | 31.1% | 7.5% | |
| – | – | – | – | – | -191.2% | -96.3% | -29.7% | -263.8% | -167.7% | -381.8% | 81.4% | |
| – | – | – | – | – | -0.2% | -0.3% | 0.1% | -0.3% | – | 65.1% | 3.2% | |
| – | – | – | – | – | -191.0% | -96.0% | -29.9% | -263.5% | -167.7% | -446.9% | 78.2% | |
| – | – | – | – | – | -138.1% | -40.9% | -27.5% | -251.2% | -158.6% | -323.6% | 92.7% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.